“Perceptronium,” Cyber Citizen Science, and RNAi: NOVA Next Week in Review

This Week’s NOVA Next Feature Article

TTR amyloidosis is debilitating and, even with today’s medicine, ultimately fatal. But there’s hope with a new therapy called RNAi. NOVA Next contributor Cassandra Willyard reports that if it works, it could cure TTR amyloidosis and open new doors for the treatment of other diseases.

In a lab in Cambridge, Massachusetts, researchers are racing to develop a cure for TTR amyloidosis.

In other news from NOVA and around the web:


Did you miss "Inside Animal Minds: Who’s the Smartest?" Stream it here—and remember, it will only be available for the next four weeks.